Healthcare provider profile · identity verified

Roxane Heiob

Nurse Practitioner · EUREKA, CA · NPI 1164834578

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Gabapentin	Gabapentin	347	45
Atorvastatin Calcium	Atorvastatin Calcium	278	35
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	267	47
Furosemide	Furosemide	257	28
Lisinopril	Lisinopril	214	24
Metoprolol Succinate	Metoprolol Succinate	213	28
Eliquis	Apixaban	195	18
Famotidine	Famotidine	183	29
Potassium Chloride	Potassium Chloride	174	18
Ozempic	Semaglutide	158	28
Sertraline Hcl	Sertraline Hcl	147	22
Trazodone Hcl	Trazodone Hcl	142	20
Levothyroxine Sodium	Levothyroxine Sodium	140	19
Pantoprazole Sodium	Pantoprazole Sodium	134	23
Tamsulosin Hcl	Tamsulosin Hcl	122	15
Bupropion Xl	Bupropion Hcl	109	14
Pregabalin	Pregabalin	104	14
Amlodipine Besylate	Amlodipine Besylate	102	17
Omeprazole	Omeprazole	99	16
Clopidogrel	Clopidogrel Bisulfate	95	suppressed
Duloxetine Hcl	Duloxetine Hcl	93	15
Losartan Potassium	Losartan Potassium	90	17
Fluticasone Propionate	Fluticasone Propionate	86	18
Baclofen	Baclofen	83	suppressed
Oxycodone Hcl	Oxycodone Hcl	81	18
Metformin Hcl	Metformin Hcl	80	suppressed
Alendronate Sodium	Alendronate Sodium	79	suppressed
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	75	13
Latanoprost	Latanoprost	75	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	73	suppressed
Nystatin	Nystatin	71	28
Mirtazapine	Mirtazapine	70	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	68	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	67	11
Carvedilol	Carvedilol	67	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	67	suppressed
Citalopram Hbr	Citalopram Hydrobromide	61	suppressed
Lorazepam	Lorazepam	61	17
Buspirone Hcl	Buspirone Hcl	59	suppressed
Ibuprofen	Ibuprofen	57	15
Methadone Hcl	Methadone Hcl	56	suppressed
Bumetanide	Bumetanide	53	suppressed
Terazosin Hcl	Terazosin Hcl	53	suppressed
Finasteride	Finasteride	52	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	51	suppressed
Clonazepam	Clonazepam	51	suppressed
Olanzapine	Olanzapine	50	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	49	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	48	suppressed
Bupropion Hcl Sr	Bupropion Hcl	46	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	45	11
Ondansetron Odt	Ondansetron	44	26
Allopurinol	Allopurinol	43	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	43	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	42	suppressed
Donepezil Hcl	Donepezil Hcl	41	suppressed
Prednisone	Prednisone	40	suppressed
Spironolactone	Spironolactone	39	suppressed
Tiadylt Er	Diltiazem Hcl	39	suppressed
Benazepril Hcl	Benazepril Hcl	38	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	38	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	37	21
Gemtesa	Vibegron	34	suppressed
Lidocaine	Lidocaine	32	11
Spiriva Respimat	Tiotropium Bromide	32	suppressed
Pravastatin Sodium	Pravastatin Sodium	31	suppressed
Alprazolam	Alprazolam	30	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	30	suppressed
Tramadol Hcl	Tramadol Hcl	30	suppressed
Chlorthalidone	Chlorthalidone	29	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	29	suppressed
Memantine Hcl	Memantine Hcl	29	suppressed
Ondansetron Hcl	Ondansetron Hcl	29	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	29	suppressed
Celecoxib	Celecoxib	28	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	28	suppressed
Montelukast Sodium	Montelukast Sodium	27	suppressed
Ramipril	Ramipril	27	suppressed
Xarelto	Rivaroxaban	27	suppressed
Cholestyramine Light	Cholestyramine	26	suppressed
Insulin Aspart Flexpen	Insulin Aspart	26	suppressed
Ranolazine Er	Ranolazine	26	suppressed
Simbrinza	Brinzolamide/Brimonidine Tart	26	suppressed
Amlodipine-Atorvastatin	Amlodipine/Atorvastatin	25	suppressed
Stiolto Respimat	Tiotropium Br/Olodaterol Hcl	25	suppressed
Cephalexin	Cephalexin	24	19
Insulin Lispro Kwikpen U-100	Insulin Lispro	24	suppressed
Serevent Diskus	Salmeterol Xinafoate	24	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	24	22
Topiramate	Topiramate	24	suppressed
Atenolol	Atenolol	23	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	23	suppressed
Prednisolone Acetate	Prednisolone Acetate	23	suppressed
Ziprasidone Hcl	Ziprasidone Hcl	23	suppressed
Divalproex Sodium	Divalproex Sodium	22	suppressed
Divalproex Sodium Er	Divalproex Sodium	22	suppressed
Novofine 32	Pen Needle, Diabetic	22	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	21	suppressed
Amiodarone Hcl	Amiodarone Hcl	20	suppressed
Risperidone	Risperidone	20	suppressed
Ropinirole Hcl	Ropinirole Hcl	20	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	19	17
Humalog Kwikpen U-200	Insulin Lispro	19	suppressed
Ketoconazole	Ketoconazole	19	13
Meloxicam	Meloxicam	19	suppressed
Naproxen	Naproxen	19	suppressed
Armour Thyroid	Thyroid,pork	18	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	18	suppressed
Lamotrigine	Lamotrigine	18	suppressed
Loperamide	Loperamide Hcl	18	11
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	17	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	17	13
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	16	suppressed
Cholestyramine	Cholestyramine (With Sugar)	16	suppressed
Lansoprazole	Lansoprazole	16	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	15	suppressed
Digoxin	Digoxin	15	suppressed
Diltiazem 24hr Er	Diltiazem Hcl	15	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	14	suppressed
Atomoxetine Hcl	Atomoxetine Hcl	14	suppressed
Estradiol	Estradiol	14	suppressed
Levofloxacin	Levofloxacin	14	suppressed
Lialda	Mesalamine	14	suppressed
Methotrexate	Methotrexate Sodium	14	suppressed
Paroxetine Hcl	Paroxetine Hcl	14	suppressed
Sulfasalazine	Sulfasalazine	14	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	14	suppressed
Bisoprolol-Hydrochlorothiazide	Bisoprolol/Hydrochlorothiazide	13	suppressed
Clonidine Hcl	Clonidine Hcl	13	suppressed
Enalapril Maleate	Enalapril Maleate	13	suppressed
Jardiance	Empagliflozin	13	suppressed
Leflunomide	Leflunomide	13	suppressed
Levetiracetam	Levetiracetam	13	suppressed
Lubiprostone	Lubiprostone	13	suppressed
Nebivolol Hcl	Nebivolol Hcl	13	suppressed
Quetiapine Fumarate Er	Quetiapine Fumarate	13	suppressed
Relistor	Methylnaltrexone Bromide	13	suppressed
Rivastigmine	Rivastigmine Tartrate	13	suppressed
Tiotropium Bromide	Tiotropium Bromide	13	suppressed
Tradjenta	Linagliptin	13	suppressed
Trulicity	Dulaglutide	13	suppressed
Warfarin Sodium	Warfarin Sodium	13	suppressed
Briviact	Brivaracetam	12	suppressed
Ciprofloxacin Hcl	Ciprofloxacin Hcl	12	suppressed
Eplerenone	Eplerenone	12	suppressed
Famciclovir	Famciclovir	12	suppressed
Lactulose	Lactulose	12	suppressed
Lidocaine Hcl Viscous	Lidocaine Hcl	12	suppressed
Simvastatin	Simvastatin	12	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	11	suppressed
Azithromycin	Azithromycin	11	suppressed
Creon	Lipase/Protease/Amylase	11	suppressed
Diclofenac Sodium	Diclofenac Sodium	11	suppressed
Fentanyl	Fentanyl	11	suppressed
Nitroglycerin	Nitroglycerin	11	suppressed
Nystop	Nystatin	11	suppressed
Oxycontin	Oxycodone Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error